v3.26.3
Consolidated Statements of Stockholders' Deficit - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Retained Deficit
Accumulated Other Comprehensive Income (Loss)
Balance at beginning of period (in shares) at Dec. 28, 2024   28,662,614      
Balance at beginning of period at Dec. 28, 2024 $ (675,586) $ 287 $ 1,568 $ (676,940) $ (501)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 92,265     92,265  
Shares issued under stock plans (in shares)   109,964      
Shares issued under stock plans 0 $ 1 (1)    
Purchases of common stock (in shares)   (830,012)      
Purchases of common stock (120,769) $ (8) (5,179) (115,582)  
Tax payments for restricted stock upon vesting (in shares)   (39,678)      
Tax payments for restricted stock upon vesting (11,597) $ (1)   (11,596)  
Stock-based compensation expense, net of forfeitures 5,312   5,312    
Dividends declared on common stock and equivalents (7,866)   (409) (7,457)  
Currency translation adjustment 3,259       3,259
Balance at end of period (in shares) at Mar. 29, 2025   27,902,888      
Balance at end of period at Mar. 29, 2025 (714,982) $ 279 1,291 (719,310) 2,758
Balance at beginning of period (in shares) at Dec. 28, 2024   28,662,614      
Balance at beginning of period at Dec. 28, 2024 (675,586) $ 287 1,568 (676,940) (501)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income $ 147,506        
Purchases of common stock (in shares) (970,115)        
Currency translation adjustment $ 6,222        
Balance at end of period (in shares) at Sep. 27, 2025   27,786,742      
Balance at end of period at Sep. 27, 2025 (702,616) $ 278 1,066 (709,681) 5,721
Balance at beginning of period (in shares) at Mar. 29, 2025   27,902,888      
Balance at beginning of period at Mar. 29, 2025 (714,982) $ 279 1,291 (719,310) 2,758
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 26,763     26,763  
Shares issued under stock plans (in shares)   28,298      
Shares issued under stock plans 855   855    
Tax payments for restricted stock upon vesting (in shares)   (7,433)      
Tax payments for restricted stock upon vesting (2,002)     (2,002)  
Stock-based compensation expense, net of forfeitures 6,217   6,217    
Dividends declared on common stock and equivalents (7,580)   (4,572) (3,008)  
Currency translation adjustment 4,731       4,731
Balance at end of period (in shares) at Jun. 28, 2025   27,923,753      
Balance at end of period at Jun. 28, 2025 (685,998) $ 279 3,791 (697,557) 7,489
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 28,478     28,478  
Shares issued under stock plans (in shares)   3,594      
Shares issued under stock plans 263   263    
Purchases of common stock (in shares)   (140,103)      
Purchases of common stock (41,084) $ (1) (1,735) (39,348)  
Tax payments for restricted stock upon vesting (in shares)   (502)      
Tax payments for restricted stock upon vesting (155)     (155)  
Stock-based compensation expense, net of forfeitures 6,072   6,072    
Dividends declared on common stock and equivalents (8,424)   (7,325) (1,099)  
Currency translation adjustment (1,768)       (1,768)
Balance at end of period (in shares) at Sep. 27, 2025   27,786,742      
Balance at end of period at Sep. 27, 2025 $ (702,616) $ 278 1,066 (709,681) 5,721
Balance at beginning of period (in shares) at Dec. 27, 2025 27,540,619 27,540,619      
Balance at beginning of period at Dec. 27, 2025 $ (736,762) $ 275 1,529 (744,915) 6,349
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 29,883     29,883  
Shares issued under stock plans (in shares)   101,952      
Shares issued under stock plans 0 $ 1 (1)    
Purchases of common stock (in shares)   (374,324)      
Purchases of common stock (78,518) $ (4) (6,034) (72,480)  
Tax payments for restricted stock upon vesting (in shares)   (35,768)      
Tax payments for restricted stock upon vesting (8,460)     (8,460)  
Stock-based compensation expense, net of forfeitures 4,823   4,823    
Dividends declared on common stock and equivalents (8,417)   (104) (8,313)  
Currency translation adjustment (1,721)       (1,721)
Balance at end of period (in shares) at Mar. 28, 2026   27,232,479      
Balance at end of period at Mar. 28, 2026 $ (799,172) $ 272 213 (804,285) 4,628
Balance at beginning of period (in shares) at Dec. 27, 2025 27,540,619 27,540,619      
Balance at beginning of period at Dec. 27, 2025 $ (736,762) $ 275 1,529 (744,915) 6,349
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income $ 90,275        
Purchases of common stock (in shares) (565,012)        
Currency translation adjustment $ (1,517)        
Balance at end of period (in shares) at Sep. 26, 2026 27,053,023 27,053,023      
Balance at end of period at Sep. 26, 2026 $ (772,548) $ 271 2,113 (779,764) 4,832
Balance at beginning of period (in shares) at Mar. 28, 2026   27,232,479      
Balance at beginning of period at Mar. 28, 2026 (799,172) $ 272 213 (804,285) 4,628
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 31,288     31,288  
Shares issued under stock plans (in shares)   8,628      
Shares issued under stock plans 354   354    
Tax payments for restricted stock upon vesting (in shares)   (756)      
Tax payments for restricted stock upon vesting (84)     (84)  
Stock-based compensation expense, net of forfeitures 3,893   3,893    
Dividends declared on common stock and equivalents (8,216)   (2,051) (6,165)  
Currency translation adjustment (1,050)       (1,050)
Balance at end of period (in shares) at Jun. 27, 2026   27,240,351      
Balance at end of period at Jun. 27, 2026 (772,987) $ 272 2,409 (779,246) 3,578
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 29,104     29,104  
Shares issued under stock plans (in shares)   3,885      
Shares issued under stock plans 274   274    
Purchases of common stock (in shares)   (190,688)      
Purchases of common stock (25,236) $ (1) (4,114) (21,121)  
Tax payments for restricted stock upon vesting (in shares)   (525)      
Tax payments for restricted stock upon vesting (54)     (54)  
Stock-based compensation expense, net of forfeitures 4,082   4,082    
Dividends declared on common stock and equivalents (8,985)   (538) (8,447)  
Currency translation adjustment $ 1,254       1,254
Balance at end of period (in shares) at Sep. 26, 2026 27,053,023 27,053,023      
Balance at end of period at Sep. 26, 2026 $ (772,548) $ 271 $ 2,113 $ (779,764) $ 4,832